glp-1 receptor agonists in idiopathic intracranial hypertension Hypertension: A Systematic Review | Headache Journal (Headache: The Journal of Head & Face Pain) posted on the topic Novel use of GLP-1 receptor
Description
Luciani, P., Fibbi, B., Mazzanti, B., Deledda, C., Ballerini, L., Aldinucci, A., et al
The country is well-positioned to become both a major producer and consumer of GLP-1 therapies
The median time elapsed from the earliest patent filing date within a given product to the expiration date of the last-to-expire patent or exclusivity on that product was 31.9 years (IQR: 29.9-36.6)
The inhibition of protein kinase C (PKC), NADPH oxidase, and NF-B signaling exhibited anti-oxidative and anti-inflammatory effects in endothelial cells, accompanied by the upregulation of protective anti-oxidative enzymes [57]
